SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 307.21 |
| Enterprise Value ($M) | 254.07 |
| Book Value ($M) | 229.17 |
| Book Value / Share | 2.13 |
| Price / Book | 1.34 |
| NCAV ($M) | 177.57 |
| NCAV / Share | 1.65 |
| Price / NCAV | 1.73 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.46 |
| Return on Assets (ROA) | -0.31 |
| Return on Equity (ROE) | -0.49 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.00 |
| Current Ratio | 8.00 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 300.81 |
| Assets | 352.42 |
| Liabilities | 123.25 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | TCG Crossover GP II, LLC | 9.80 | ||
| 13D/A | Boxer Capital Management, LLC | 6.50 | 0.00 | |
| 13D/A | Boxer Asset Management Inc. | 0.00 | ||
| 13D/A | Boxer Capital, LLC | 7.80 | ||
| 13D/A | Third Rock Ventures IV, L.P. | 15.90 | -12.20 | |
| 13G/A | Southpoint Capital Advisors LP | 4.90 | 0.00 | |
| 13G/A | Gilead Sciences Inc | 4.80 | 0.00 | |
| 13G/A | Fmr Llc | 9.60 | -27.76 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 203,709 | 660,760 | 30.83 | |
| 124,430 | 607,753 | 20.47 | |
| 138,738 | 534,503 | 25.96 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TCRX – TScan Therapeutics, Inc. | TKNO – Alpha Teknova, Inc. |
| TLPH – Talphera, Inc. | TRDA – Entrada Therapeutics, Inc. |
| TRVI – Trevi Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io